Zoeken | Myliveroom — Live Events & Online Communities

Rishika Datta toegevoegd een audio Health
2026-03-13 09:25:33 - Translate -

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies
According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

0 Reacties 0 aandelen 5K Views 0 voorbeeld

Please log in to like, share and comment!
Naznin Shaikh toegevoegd een audio Film
2026-03-06 08:53:40 - Translate -

Emerging Trends Influencing the Antibody Drug Conjugates Market
Asia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...

0 Reacties 0 aandelen 8K Views 0 voorbeeld

Please log in to like, share and comment!
Rishika Datta toegevoegd een audio Health
2026-03-16 06:24:30 - Translate -

Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology Adoption
According to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...

0 Reacties 0 aandelen 3K Views 0 voorbeeld

Please log in to like, share and comment!
Violet Mac toegevoegd een audio Health
2026-05-15 07:47:09 - Translate -

Global Cervical Cancer Therapeutics Market Future Growth Prospects
The global cervical cancer therapeutics market size was valued at USD 6.33 billion in 2024 and is expected to grow from USD 6.61 billion in 2025 to reach USD 9.38 billion in 2033, growing at a CAGR of 4.47% during the forecast period (2025–2033). Key Highlights North America dominated the global cervical cancer therapeutics market and is expected to maintain its leading...

0 Reacties 0 aandelen 1K Views 0 voorbeeld

Please log in to like, share and comment!
Ksh Dbmr toegevoegd een audio Networking
2026-04-15 06:06:55 - Translate -

How Are Treatments Advancing in Metastatic Solid Tumors Market?
Executive Summary Metastatic Solid Tumors Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029. The Metastatic Solid Tumors report is an ultimate solution for businesses if they want to stay ahead of the competition in today's fast-moving business...

0 Reacties 0 aandelen 2K Views 0 voorbeeld

Please log in to like, share and comment!
Naznin Shaikh toegevoegd een audio Fitness
2026-03-06 09:22:35 - Translate -

Immunotherapy Impact on the Anti-cancer Drugs Market
The rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...

0 Reacties 0 aandelen 5K Views 0 voorbeeld

Please log in to like, share and comment!
Rishika Datta toegevoegd een audio Other
2026-03-13 10:10:59 - Translate -

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Reacties 0 aandelen 3K Views 0 voorbeeld

Please log in to like, share and comment!